Search Results - "Polášek, M."

Refine Results
  1. 1

    Calculation of the pharmacogenomics benefit score for patients with medication-related problems by Polasek, Thomas M

    Published in Frontiers in genetics (05-05-2023)
    “…Unexpected poor efficacy and intolerable adverse effects are medication-related problems that may result from genetic variation in genes encoding key proteins…”
    Get full text
    Journal Article
  2. 2

    Sequential injection technique applied to pharmaceutical analysis by Solich, P, Polášek, M, Klimundová, J, Ruzicka, J

    “…The versatility of sequential injection analysis (SIA), based on programmable flow, has been recently enhanced by the miniaturization implemented in…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Contrasting Dynamics in Isoelectronic Anions Formed by Electron Attachment by Nag, P., Ranković, M., Polášek, M., Čurík, R., Slaughter, D. S., Fedor, J.

    Published in The journal of physical chemistry letters (01-02-2024)
    “…Cyanogen NCCN and cyanoacetylene HCCCN are isoelectronic molecules, and as such, they have many similar properties. We focus on the bond cleavage in these…”
    Get full text
    Journal Article
  5. 5

    The reactivity of methanimine radical cation (H2CNH•+) and its isomer aminomethylene (HCNH2•+) with C2H4 by Sundelin, D., Ascenzi, D., Richardson, V., Alcaraz, C., Polášek, M., Romanzin, C., Thissen, R., Tosi, P., Žabka, J., Geppert, W.

    Published in Chemical physics letters (16-08-2021)
    “…[Display omitted] •Cationic isomers of methanimine generated via dissociative photoionization.•Reactive cross sections and branching ratios with C2H4 as a…”
    Get full text
    Journal Article
  6. 6
  7. 7

    The reactivity of methanimine radical cation (H2CNH+) and its isomer aminomethylene (HCNH2+) with methane by Richardson, V., Alcaraz, C., Geppert, W.D., Polášek, M., Romanzin, C., Sundelin, D., Thissen, R., Tosi, P., Žabka, J., Ascenzi, D.

    Published in Chemical physics letters (16-07-2021)
    “…[Display omitted] •Cationic isomers of methanimine generated via dissociative photoionization.•Isomers react with methane by H atom transfer to give protonated…”
    Get full text
    Journal Article
  8. 8

    Virtual twin for healthcare management by Polasek, Thomas M.

    Published in Frontiers in digital health (15-09-2023)
    “…Healthcare is increasingly fragmented, resulting in escalating costs, patient dissatisfaction, and sometimes adverse clinical outcomes. Strategies to decrease…”
    Get full text
    Journal Article
  9. 9

    Personality vulnerabilities and adverse event reporting in phase 1 clinical studies by Skommer, Joanna, Gunesh, Krish, Polasek, Thomas M

    “…Phase 1 clinical trials involve rigorous safety monitoring to identify any adverse effects of investigational treatments. There is growing evidence that…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Quantifying the Impact of Phenoconversion on Medications With Actionable Pharmacogenomic Guideline Recommendations in an Acute Aged Persons Mental Health Setting by Mostafa, Sam, Polasek, Thomas M., Sheffield, Leslie J., Huppert, David, Kirkpatrick, Carl M. J.

    Published in Frontiers in psychiatry (19-08-2021)
    “…Introduction: Polypharmacy and genetic variants that strongly influence medication response (pharmacogenomics, PGx) are two well-described risk factors for…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Artificial Intelligence and Machine Learning Applied at the Point of Care by Angehrn, Zuzanna, Haldna, Liina, Zandvliet, Anthe S, Gil Berglund, Eva, Zeeuw, Joost, Amzal, Billy, Cheung, S Y Amy, Polasek, Thomas M, Pfister, Marc, Kerbusch, Thomas, Heckman, Niedre M

    Published in Frontiers in pharmacology (18-06-2020)
    “…The increasing availability of healthcare data and rapid development of big data analytic methods has opened new avenues for use of Artificial Intelligence…”
    Get full text
    Journal Article
  14. 14

    In Vitro Characterization of the Human Liver Microsomal Kinetics and Reaction Phenotyping of Olanzapine Metabolism by Korprasertthaworn, Porntipa, Polasek, Thomas M, Sorich, Michael J, McLachlan, Andrew J, Miners, John O, Tucker, Geoffrey T, Rowland, Andrew

    Published in Drug metabolism and disposition (01-11-2015)
    “…Olanzapine (OLZ) is an atypical antipsychotic used in the treatment of schizophrenia and related psychoses. The metabolism of OLZ is complex and incompletely…”
    Get full text
    Journal Article
  15. 15

    Efficacy and safety of pharmacogenomic-guided antidepressant prescribing in patients with depression: an umbrella review and updated meta-analysis by Tesfamicael, Kiflu G, Zhao, Lijun, Fernández-Rodríguez, Rubén, Adelson, David L, Musker, Michael, Polasek, Thomas M, Lewis, Martin David

    Published in Frontiers in psychiatry (11-07-2024)
    “…To determine the efficacy and safety of pharmacogenomics (PGx)-guided antidepressant prescribing in patients with depression through an umbrella review and…”
    Get full text
    Journal Article
  16. 16

    Delineating gene–environment effects using virtual twins of patients treated with clozapine by Mostafa, Sam, Polasek, Thomas M., Bousman, Chad, Rostami‐Hodjegan, Amin, Sheffield, Leslie J., Everall, Ian, Pantelis, Christos, Kirkpatrick, Carl M. J.

    “…Studies that focus on individual covariates, while ignoring their interactions, may not be adequate for model‐informed precision dosing (MIPD) in any given…”
    Get full text
    Journal Article
  17. 17

    Determination of bopindolol in pharmaceuticals by capillary isotachophoresis by URBANEK, M, POSPISILOVA, M, POLASEK, M

    “…Capillary isotachophoresis (ITP) with conductimetric detection has been used for separating and determining bopindolol ( I) in commercial mass-produced…”
    Get full text
    Journal Article
  18. 18

    Pharmacogenomics in general practice: The time has come by Polasek, Thomas M, Mina, Kym, Suthers, Graeme

    Published in Australian journal of general practice (01-03-2019)
    “…Patients respond to medications differently because of variations in the genes that determine medication exposure and medication response. The aim of this…”
    Get more information
    Journal Article
  19. 19

    Virtual twins for model‐informed precision dosing of clozapine in patients with treatment‐resistant schizophrenia by Mostafa, Sam, Rafizadeh, Reza, Polasek, Thomas M., Bousman, Chad A., Rostami‐Hodjegan, Amin, Stowe, Robert, Carrion, Prescilla, Sheffield, Leslie J., Kirkpatrick, Carl M. J.

    “…Model‐informed precision dosing using virtual twins (MIPD‐VTs) is an emerging strategy to predict target drug concentrations in clinical practice. Using a high…”
    Get full text
    Journal Article
  20. 20

    Combining Therapeutic Drug Monitoring and Pharmacokinetic Modelling Deconvolutes Physiological and Environmental Sources of Variability in Clozapine Exposure by Wills, Kenneth H, Behan, Stephen J, Nance, Michael J, Dawson, Jessica L, Polasek, Thomas M, Hopkins, Ashley M, van Dyk, Madelé, Rowland, Andrew

    Published in Pharmaceutics (27-12-2021)
    “…Clozapine is a key antipsychotic drug for treatment-resistant schizophrenia but exhibits highly variable pharmacokinetics and a propensity for serious adverse…”
    Get full text
    Journal Article